Alcoholic Liver Disease and Methionine Metabolism

 

 Buy Article Permissions and Reprints

ABSTRACT

Alcoholic liver disease is a major health care problem worldwide. Findings have demonstrated that ethanol feeding impairs several of the multiple steps in methionine metabolism that leads to progressive liver injury. Ethanol consumption has been reported to predominantly inhibit the activity of a vital cellular enzyme, methionine synthase, involved in remethylating homocysteine. By way of compensation in some species, ethanol can also increase the activity of the enzyme, betaine homocysteine methyltransferase. This enzyme catalyzes an alternate pathway in methionine metabolism and utilizes hepatic betaine to remethylate homocysteine to form methionine and maintain levels of S-adenosylmethionine, the key methylating agent. Under extended periods of ethanol feeding, however, this alternate pathway cannot be maintained. This results in a decrease in the hepatocyte level of S-adenosylmethionine and increases in two toxic metabolites, S-adenosylhomocysteine and homocysteine. These changes in the various metabolites of methionine metabolism, in turn, result in serious functional consequences. These include decreases in essential methylation reactions by inhibiting various methyltransferases critical to normal functioning of the liver and upregulation of the activation of endoplasmic reticulum-dependent apoptosis and lipid synthetic pathways. The ultimate outcome of these consequences is increased fat deposition, increased apoptosis, accumulation of damaged proteins, and alterations in various signaling pathways, all of which can ultimately result in progressive liver damage.

Of all the therapeutic modalities that are presently being used to attenuate ethanol-induced liver injury, betaine has been shown to be the most effective in a variety of experimental models of liver disease. Betaine, by virtue of aiding in the remethylation of homocysteine, removes both toxic metabolites (homocysteine and S-adenosylhomocysteine), restores S-adenosylmethionine level, reverses steatosis, prevents apoptosis and reduces both damaged protein accumulation and oxidative stress. Thus, betaine is a promising therapeutic agent in relieving the methylation and other defects associated with alcoholic abuse.

REFERENCES

• 1 Ishak K G, Zimmerman H J, Ray M B. Alcoholic liver disease: pathologic, pathogenetic, and clinical aspects.  Alcohol Clin Exp Res. 1991;  15 45-66
  CrossrefPubMedGoogle Scholar
• 2 Finkelstein J D, Martin J J. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways.  J Biol Chem. 1984;  259 9508-9513
  PubMedGoogle Scholar
• 3 Finkelstein J D, Mudd S H. Trans-sulfuration in mammals. The methionine-sparing effect of cystine.  J Biol Chem. 1967;  242 873-880
  PubMedGoogle Scholar
• 4 Schubert H L, Blumenthal R M, Cheng X. Many paths to methyltransfer: a chronicle of convergence.  Trends Biochem Sci. 2003;  28 329-335
  CrossrefPubMedGoogle Scholar
• 5 Mudd S H, Brosnan J T, Brosnan M E et al.. Methyl balance and transmethylation fluxes in humans.  Am J Clin Nutr. 2007;  85 19-25
  PubMedGoogle Scholar
• 6 Barak A J, Baker H, Tuma D J. Influence of ethanol on in-vivo levels of hepatic methylators betaine and N5-methyltetrahydrofolate in the rat.  IRCS Med Sci. 1981;  9 527-528
  PubMedGoogle Scholar
• 7 Barak A J, Beckenhauer H C, Tuma D J. Ethanol feeding inhibits the activity of N5-methyltetrahydrofolate-homocysteine methyltransferase in the rat.  IRCS Med Sci. 1985;  13 760-761
  PubMedGoogle Scholar
• 8 Barak A J, Beckenhauer H C, Tuma D J, Badakhsh S. Effects of prolonged ethanol feeding on methionine metabolism in rat liver.  Biochem Cell Biol. 1987;  65 230-233
  CrossrefPubMedGoogle Scholar
• 9 Trimble K C, Molloy A M, Scott J M, Weir D G. The effect of ethanol on one-carbon metabolism: increased methionine catabolism and lipotrope methyl-group wastage.  Hepatology. 1993;  18 984-989
  CrossrefPubMedGoogle Scholar
• 10 Halsted C H, Villanueva J, Chandler C J et al.. Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation.  Hepatology. 1996;  23 497-505
  CrossrefPubMedGoogle Scholar
• 11 Halsted C H, Villanueva J A, Devlin A M et al.. Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig.  Proc Natl Acad Sci U S A. 2002;  99 10072-10077
  CrossrefPubMedGoogle Scholar
• 12 Villanueva J A, Halsted C H. Hepatic transmethylation reactions in micropigs with alcoholic liver disease.  Hepatology. 2004;  39 1303-1310
  CrossrefPubMedGoogle Scholar
• 13 Avila M A, Berasain C, Torres L et al.. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma.  J Hepatol. 2000;  33 907-914
  CrossrefPubMedGoogle Scholar
• 14 Ji C, Deng Q, Kaplowitz N. Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury.  Hepatology. 2004;  40 442-451
  CrossrefPubMedGoogle Scholar
• 15 Kenyon S H, Nicolaou A, Gibbons W A. The effect of ethanol and its metabolites upon methionine synthase activity in vitro.  Alcohol. 1998;  15 305-309
  CrossrefPubMedGoogle Scholar
• 16 Barak A J, Beckenhauer H C, Tuma D J. Betaine effects on hepatic methionine metabolism elicited by short-term ethanol feeding.  Alcohol. 1996;  13 483-486
  CrossrefPubMedGoogle Scholar
• 17 Kharbanda K K, Mailliard M E, Baldwin C R et al.. Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway.  J Hepatol. 2007;  46 314-321
  CrossrefPubMedGoogle Scholar
• 18 Seth D, Leo M A, McGuinness P H et al.. Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver.  Am J Pathol. 2003;  163 2303-2317
  PubMedGoogle Scholar
• 19 Look M P, Riezler R, Reichel C et al.. Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase?.  Scand J Gastroenterol. 2000;  35 866-872
  CrossrefPubMedGoogle Scholar
• 20 Barak A J, Beckenhauer H C, Tuma D J, Donohue T M. Adaptive increase in betaine-homocysteine methyltransferase activity maintains hepatic S-adenosylmethionine levels in ethanol-treated rats.  IRCS Med Sci. 1984;  12 866-867
  PubMedGoogle Scholar
• 21 Chern M K, Gage D A, Pietruszko R. Betaine aldehyde, betaine, and choline levels in rat livers during ethanol metabolism.  Biochem Pharmacol. 2000;  60 1629-1637
  CrossrefPubMedGoogle Scholar
• 22 Barak A J, Beckenhauer H C, Junnila M, Tuma D J. Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration.  Alcohol Clin Exp Res. 1993;  17 552-555
  CrossrefPubMedGoogle Scholar
• 23 Lu S C, Huang Z Z, Yang H et al.. Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver.  Am J Physiol Gastrointest Liver Physiol. 2000;  279 G178-G185
  PubMedGoogle Scholar
• 24 Lieber C S, Casini A, DeCarli L M et al.. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon.  Hepatology. 1990;  11 165-172
  CrossrefPubMedGoogle Scholar
• 25 Villanueva J A, Esfandiari F, Wong D H et al.. Abnormal transsulfuration and glutathione metabolism in the micropig model of alcoholic liver disease.  Alcohol Clin Exp Res. 2006;  30 1262-1270
  CrossrefPubMedGoogle Scholar
• 26 Martinez-Lopez N, Varela-Rey M, Ariz U et al.. S-adenosylmethionine and proliferation: new pathways, new targets.  Biochem Soc Trans. 2008;  36 848-852
  CrossrefPubMedGoogle Scholar
• 27 Mato J M, Corrales F J, Lu S C, Avila M A. S-Adenosylmethionine: a control switch that regulates liver function.  FASEB J. 2002;  16 15-26
  CrossrefPubMedGoogle Scholar
• 28 Lee T D, Sadda M R, Mendler M H et al.. Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis.  Alcohol Clin Exp Res. 2004;  28 173-181
  CrossrefPubMedGoogle Scholar
• 29 Alvarez L, Corrales F, Martin-Duce A, Mato J M. Characterization of a full-length cDNA encoding human liver S-adenosylmethionine synthetase: tissue-specific gene expression and mRNA levels in hepatopathies.  Biochem J. 1993;  293 481-486
  PubMedGoogle Scholar
• 30 Finkelstein J D, Cello J P, Kyle W E. Ethanol-induced changes in methionine metabolism in rat liver.  Biochem Biophys Res Commun. 1974;  61 525-531
  CrossrefPubMedGoogle Scholar
• 31 Cabrero C, Duce A M, Ortiz P et al.. Specific loss of the high-molecular-weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis.  Hepatology. 1988;  8 1530-1534
  CrossrefPubMedGoogle Scholar
• 32 Duce A M, Ortiz P, Cabrero C, Mato J M. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis.  Hepatology. 1988;  8 65-68
  CrossrefPubMedGoogle Scholar
• 33 Jewell S A, Di Monte D, Gentile A et al.. Decreased hepatic glutathione in chronic alcoholic patients.  J Hepatol. 1986;  3 1-6
  CrossrefPubMedGoogle Scholar
• 34 Lu S C, Huang Z Z, Yang J M, Tsukamoto H. Effect of ethanol and high-fat feeding on hepatic gamma-glutamylcysteine synthetase subunit expression in the rat.  Hepatology. 1999;  30 209-214
  CrossrefPubMedGoogle Scholar
• 35 Fernandez-Checa J C, Ookhtens M, Kaplowitz N. Effects of chronic ethanol feeding on rat hepatocytic glutathione. Relationship of cytosolic glutathione to efflux and mitochondrial sequestration.  J Clin Invest. 1989;  83 1247-1252
  CrossrefPubMedGoogle Scholar
• 36 Fernandez-Checa J C, Garcia-Ruiz C, Ookhtens M, Kaplowitz N. Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress.  J Clin Invest. 1991;  87 397-405
  CrossrefPubMedGoogle Scholar
• 37 Hirano T, Kaplowitz N, Tsukamoto H et al.. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats.  Hepatology. 1992;  16 1423-1427
  CrossrefPubMedGoogle Scholar
• 38 Fernandez-Checa J C, Hirano T, Tsukamoto H, Kaplowitz N. Mitochondrial glutathione depletion in alcoholic liver disease.  Alcohol. 1993;  10 469-475
  CrossrefPubMedGoogle Scholar
• 39 Garcia-Ruiz C, Morales A, Ballesta A et al.. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes.  J Clin Invest. 1994;  94 193-201
  CrossrefPubMedGoogle Scholar
• 40 Fernandez-Checa J C, Kaplowitz N. Hepatic mitochondrial glutathione: transport and role in disease and toxicity.  Toxicol Appl Pharmacol. 2005;  204 263-273
  CrossrefPubMedGoogle Scholar
• 41 Wheeler M D, Nakagami M, Bradford B U et al.. Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat.  J Biol Chem. 2001;  276 36664-36672
  CrossrefPubMedGoogle Scholar
• 42 Colell A, Garcia-Ruiz C, Morales A et al.. Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: effect of membrane physical properties and S-adenosyl-L-methionine.  Hepatology. 1997;  26 699-708
  PubMedGoogle Scholar
• 43 Coll O, Colell A, Garcia-Ruiz C et al.. Sensitivity of the 2-oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion.  Hepatology. 2003;  38 692-702
  PubMedGoogle Scholar
• 44 Lluis J M, Colell A, Garcia-Ruiz C et al.. Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress.  Gastroenterology. 2003;  124 708-724
  CrossrefPubMedGoogle Scholar
• 45 Bailey S M, Patel V B, Young T A et al.. Chronic ethanol consumption alters the glutathione/glutathione peroxidase-1 system and protein oxidation status in rat liver.  Alcohol Clin Exp Res. 2001;  25 726-733
  CrossrefPubMedGoogle Scholar
• 46 Deaciuc I V, Fortunato F, D'Souza N B et al.. Modulation of caspase-3 activity and Fas ligand mRNA expression in rat liver cells in vivo by alcohol and lipopolysaccharide.  Alcohol Clin Exp Res. 1999;  23 349-356
  PubMedGoogle Scholar
• 47 Hultberg B, Berglund M, Andersson A, Frank A. Elevated plasma homocysteine in alcoholics.  Alcohol Clin Exp Res. 1993;  17 687-689
  CrossrefPubMedGoogle Scholar
• 48 Cravo M L, Camilo M E. Hyperhomocysteinemia in chronic alcoholism: relations to folic acid and vitamins B(6) and B(12) status.  Nutrition. 2000;  16 296-302
  CrossrefPubMedGoogle Scholar
• 49 Stickel F, Choi S W, Kim Y I et al.. Effect of chronic alcohol consumption on total plasma homocysteine level in rats.  Alcohol Clin Exp Res. 2000;  24 259-264
  CrossrefPubMedGoogle Scholar
• 50 Ji C, Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice.  Gastroenterology. 2003;  124 1488-1499
  CrossrefPubMedGoogle Scholar
• 51 Bleich S, Bandelow B, Javaheripour K et al.. Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism.  Neurosci Lett. 2003;  335 179-182
  Google Scholar
• 52 Bonsch D, Lenz B, Reulbach U et al.. Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism.  J Neural Transm. 2004;  111 1611-1616
  CrossrefPubMedGoogle Scholar
• 53 Blasco C, Caballeria J, Deulofeu R et al.. Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics.  Alcohol Clin Exp Res. 2005;  29 1044-1048
  CrossrefPubMedGoogle Scholar
• 54 Barak A J, Beckenhauer H C, Kharbanda K K, Tuma D J. Chronic ethanol consumption increases homocysteine accumulation in hepatocytes.  Alcohol. 2001;  25 77-81
  CrossrefPubMedGoogle Scholar
• 55 Finkelstein J D, Martin J J, Harris B J, Kyle W E. Regulation of the betaine content of rat liver.  Arch Biochem Biophys. 1982;  218 169-173
  CrossrefPubMedGoogle Scholar
• 56 Refsum H, Fiskerstrand T, Guttormsen A B, Ueland P M. Assessment of homocysteine status.  J Inherit Metab Dis. 1997;  20 286-294
  CrossrefPubMedGoogle Scholar
• 57 Barak A J, Beckenhauer H C, Mailliard M E et al.. Betaine lowers elevated S-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats.  J Nutr. 2003;  133 2845-2848
  PubMedGoogle Scholar
• 58 Song Z, Zhou Z, Song M et al.. Alcohol-induced S-adenosylhomocysteine accumulation in the liver sensitizes to TNF hepatotoxicity: possible involvement of mitochondrial S-adenosylmethionine transport.  Biochem Pharmacol. 2007;  74 521-531
  CrossrefPubMedGoogle Scholar
• 59 Clarke S, Banfield K. S-adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobsen DW Homocysteine in Health and Disease. Cambridge; Cambridge University Press 2001: 63-78
  Google Scholar
• 60 Noga A A, Zhao Y, Vance D E. An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins.  J Biol Chem. 2002;  277 42358-42365
  CrossrefPubMedGoogle Scholar
• 61 Zhu X, Song J, Mar M H et al.. Phosphatidylethanolamine-N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline.  Biochem J. 2003;  370 987-993
  CrossrefPubMedGoogle Scholar
• 62 Nishimaki-Mogami T, Yao Z, Fujimori K. Inhibition of phosphatidylcholine synthesis via the phosphatidylethanolamine methylation pathway impairs incorporation of bulk lipids into VLDL in cultured rat hepatocytes.  J Lipid Res. 2002;  43 1035-1045
  CrossrefPubMedGoogle Scholar
• 63 Rando R R. Chemical biology of isoprenylation/methylation.  Biochem Soc Trans. 1996;  24 682-687
  PubMedGoogle Scholar
• 64 Kramer K, Harrington E O, Lu Q et al.. Isoprenylcysteine carboxyl methyltransferase activity modulates endothelial cell apoptosis.  Mol Biol Cell. 2003;  14 848-857
  CrossrefPubMedGoogle Scholar
• 65 Shimizu T, Matsuoka Y, Shirasawa T. Biological significance of isoaspartate and its repair system.  Biol Pharm Bull. 2005;  28 1590-1596
  CrossrefPubMedGoogle Scholar
• 66 Clarke S. Aging as war between chemical and biochemical processes: protein methylation and the recognition of age-damaged proteins for repair.  Ageing Res Rev. 2003;  2 263-285
  PubMedGoogle Scholar
• 67 Doyle H A, Zhou J, Wolff M J et al.. Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity.  J Biol Chem. 2006;  281 32676-32683
  CrossrefPubMedGoogle Scholar
• 68 Vigneswara V, Lowenson J D, Powell C D et al.. Proteomic identification of novel substrates of a protein isoaspartyl methyltransferase repair enzyme.  J Biol Chem. 2006;  281 32619-32629
  CrossrefPubMedGoogle Scholar
• 69 Boisvert F M, Cote J, Boulanger M C, Richard S. A proteomic analysis of arginine-methylated protein complexes.  Mol Cell Proteomics. 2003;  2 1319-1330
  PubMedGoogle Scholar
• 70 Kharbanda K K, Rogers II D D, Mailliard M E et al.. Role of elevated S-adenosylhomocysteine in rat hepatocyte apoptosis: protection by betaine.  Biochem Pharmacol. 2005;  70 1883-1890
  CrossrefPubMedGoogle Scholar
• 71 Kharbanda K K, Rogers II D D, Beckenhauer H C et al.. Tubercidin-induced apoptosis via increased hepatocellular levels of S-adenosylhomocysteine is attenuated by betaine administration.  Alcohol Clin Exp Res. 2005;  29 182A
  PubMedGoogle Scholar
• 72 Kharbanda K K, Mailliard M E, Baldwin C R et al.. Accumulation of proteins bearing atypical isoaspartyl residues in livers of alcohol-fed rats is prevented by betaine administration: effects on protein-l-isoaspartyl methyltransferase activity.  J Hepatol. 2007;  46 1119-1125
  CrossrefPubMedGoogle Scholar
• 73 Carter W G, Vigneswara V, Atkins R et al.. Proteomic characterization of both altered protein level and isoaspartate carboxyl methylation in a model of alcoholic liver disease.  Alcohol Clin Exp Res. 2008;  32 343A
  PubMedGoogle Scholar
• 74 Osna N A, Donohue T M, White R L et al.. Ethanol and hepatic C viral proteins regulate interferon signaling in liver cells via impaired methylation of Stat1.  Hepatology. 2008;  48 327A
  PubMedGoogle Scholar
• 75 Kharbanda K K. Role of transmethylation reactions in alcoholic liver disease.  World J Gastroenterol. 2007;  13 4947-4954
  PubMedGoogle Scholar
• 76 Jakubowski H. Pathophysiological consequences of homocysteine excess.  J Nutr. 2006;  136 1741S-1749S
  PubMedGoogle Scholar
• 77 Torres L, Garcia-Trevijano E R, Rodriguez J A et al.. Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis.  Biochim Biophys Acta. 1999;  1455 12-22
  PubMedGoogle Scholar
• 78 Ji C, Chan C, Kaplowitz N. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model.  J Hepatol. 2006;  45 717-724
  CrossrefPubMedGoogle Scholar
• 79 Esfandiari F, Villanueva J A, Wong D H et al.. Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs.  Am J Physiol Gastrointest Liver Physiol. 2005;  289 G54-G63
  CrossrefPubMedGoogle Scholar
• 80 Ji C, Kaplowitz N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury.  World J Gastroenterol. 2004;  10 1699-1708
  PubMedGoogle Scholar
• 81 Ji C. Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury.  J Gastroenterol Hepatol. 2008;  23(Suppl 1) S16-S24
  CrossrefPubMedGoogle Scholar
• 82 Shukla S D, Aroor A R. Epigenetic effects of ethanol on liver and gastrointestinal injury.  World J Gastroenterol. 2006;  12 5265-5271
  PubMedGoogle Scholar
• 83 Pal-Bhadra M, Bhadra U, Jackson D E et al.. Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up- & down-regulation of genes by ethanol in hepatocytes.  Life Sci. 2007;  81 979-987
  CrossrefPubMedGoogle Scholar
• 84 Shukla S D, Velazquez J, French S W et al.. Emerging role of epigenetics in the actions of alcohol.  Alcohol Clin Exp Res. 2008;  32 1525-1534
  CrossrefPubMedGoogle Scholar
• 85 Bardag-Gorce F, Dedes J, French B A et al.. Mallory body formation is associated with epigenetic phenotypic change in hepatocytes in vivo.  Exp Mol Pathol. 2007;  83 160-168
  CrossrefPubMedGoogle Scholar
• 86 Bardag-Gorce F, French B A, Joyce M et al.. Histone acetyltransferase p300 modulates gene expression in an epigenetic manner at high blood alcohol levels.  Exp Mol Pathol. 2007;  82 197-202
  CrossrefPubMedGoogle Scholar
• 87 Baric I, Fumic K, Glenn B et al.. S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism.  Proc Natl Acad Sci U S A. 2004;  101 4234-4239
  CrossrefPubMedGoogle Scholar
• 88 Kloor D, Fumic K, Attig S et al.. Studies of S-adenosylhomocysteine-hydrolase polymorphism in a Croatian population.  J Hum Genet. 2006;  51 21-24
  CrossrefPubMedGoogle Scholar
• 89 Kharbanda K K, Rogers II D D, Mailliard M E et al.. A comparison of the effects of betaine and S-adenosylmethionine on ethanol-induced changes in methionine metabolism and steatosis in rat hepatocytes.  J Nutr. 2005;  135 519-524
  PubMedGoogle Scholar
• 90 Craig S A. Betaine in human nutrition.  Am J Clin Nutr. 2004;  80 539-549
  Google Scholar
• 91 Kanbak G, Inal M, Baycu C. Ethanol-induced hepatotoxicity and protective effect of betaine.  Cell Biochem Funct. 2001;  19 281-285
  CrossrefPubMedGoogle Scholar
• 92 Balkan J, Oztezcan S, Kucuk M et al.. The effect of betaine treatment on triglyceride levels and oxidative stress in the liver of ethanol-treated guinea pigs.  Exp Toxicol Pathol. 2004;  55 505-509
  CrossrefPubMedGoogle Scholar
• 93 Kim S J, Jung Y S, Kwon do Y, Kim Y C. Alleviation of acute ethanol-induced liver injury and impaired metabolomics of S-containing substances by betaine supplementation.  Biochem Biophys Res Commun. 2008;  368 893-898
  CrossrefPubMedGoogle Scholar
• 94 Lieber C S, Packer L. S-Adenosylmethionine: molecular, biological, and clinical aspects–an introduction.  Am J Clin Nutr. 2002;  76 1148S-1150S
  PubMedGoogle Scholar
• 95 Purohit V, Abdelmalek M F, Barve S et al.. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium.  Am J Clin Nutr. 2007;  86 14-24
  PubMedGoogle Scholar
• 96 Seitz H K, Lieber C S, Stickel F et al.. Alcoholic liver disease: from pathophysiology to therapy.  Alcohol Clin Exp Res. 2005;  29 1276-1281
  CrossrefPubMedGoogle Scholar
• 97 Barve S, Joshi-Barve S, Song Z et al.. Interactions of cytokines, S-adenosylmethionine, and S-adenosylhomocysteine in alcohol-induced liver disease and immune suppression.  J Gastroenterol Hepatol. 2006;  21(Suppl 3) S38-S42
  CrossrefPubMedGoogle Scholar
• 98 Barve A, Khan R, Marsano L et al.. Treatment of alcoholic liver disease.  Ann Hepatol. 2008;  7 5-15
  PubMedGoogle Scholar
• 99 Yang H, Sadda M R, Li M et al.. S-adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: role of protein phosphatase 1 and Bcl-x(S).  Hepatology. 2004;  40 221-231
  CrossrefPubMedGoogle Scholar
• 100 Lu S C, Martinez-Chantar M L, Mato J M. Methionine adenosyltransferase and S-adenosylmethionine in alcoholic liver disease.  J Gastroenterol Hepatol. 2006;  21(Suppl 3) S61-S64
  CrossrefPubMedGoogle Scholar
• 101 Friedel H A, Goa K L, Benfield P. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.  Drugs. 1989;  38 389-416
  CrossrefPubMedGoogle Scholar
• 102 Olthof M R, Verhoef P. Effects of betaine intake on plasma homocysteine concentrations and consequences for health.  Curr Drug Metab. 2005;  6 15-22
  Google Scholar
• 103 Mato J M, Camara J, Fernandez de Paz J et al.. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.  J Hepatol. 1999;  30 1081-1089
  CrossrefPubMedGoogle Scholar
• 104 Rambaldi A, Gluud C. S-adenosyl-l-methionine for alcoholic liver diseases.  Cochrane Database Syst Rev. 2006;  CD002235
  PubMedGoogle Scholar

Kusum K KharbandaPh.D. 

Department of Veterans Affairs Medical Center, Research Service (151)

4101 Woolworth Avenue, Omaha, NE 68105

Email: kkharbanda@unmc.edu